Spine Pacira BioSciences Announces Results From 12-Month Pilot Study Demonstrating Favorable Safety and Significant Improvements in Pain With iovera° Compared to Radiofrequency Ablation in Chronic Low Back Pain byTim AllenDecember 2, 2025
Neuro Spine Aclarion Announces Use of MR Spectroscopy for identifying Biomarkers of Discogenic Pain highlighted at Global Neuroscience Conference byTim AllenOctober 13, 2025
Spine Top Stories Aclarion Honored as Finalist for the 2025 Digital Health Hub Foundation: Digital Health Awards at HLTH byJosh SandbergOctober 7, 2025
Spine First Patients Enrolled at UHealth – University of Miami in Aclarion’s Pivotal CLARITY Trial byTim AllenSeptember 25, 2025
Biologics Spine Vivex Biologics, Inc. Completes Subject Enrollment for its ASCEND Trial Evaluating VIA Disc NP™ for Symptomatic Disc Degeneration byJosh SandbergJuly 29, 2025
Spine ReGelTec Announces First Patient Treated in U.S. IDE Clinical Trial for HYDRAFIL System to Treat Chronic Low Back Pain byJosh SandbergJune 18, 2025
Regulatory Spine Stryker receives FDA clearance for OptaBlate® BVN Basivertebral Nerve Ablation System byTim AllenMay 19, 2025
Spine Top Stories Spine BioPharma, Inc. Announces Completion of Enrollment for Phase 3 Clinical Trial of SB-01 to Address Chronic Low Back Pain byJosh SandbergSeptember 24, 2024
Spine PRISM MarketView Showcases Aclarion: Disrupting Chronic Pain Treatment with Nociscan AI Technology byJosh SandbergSeptember 13, 2024
Spine Aclarion’s Nociscan Solution to Play Key Role in Groundbreaking LIFEHAB Trial Evaluating the Diagnosis and Treatment of Chronic Low Back Pain byTim AllenApril 25, 2024
